Referenser

  1. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27.

  2. SBU. Läkemedelsbehandling av vanliga smärttillstånd hos äldre personer – effekter, biverkningar samt upplevelser av vård: en systematisk litteraturöversikt. In: (SBU) Sbfmosu, editor. Stockholm 2020.

  3. Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019;393(10180):1537-46.

  4. Werner M.U BE, (red). Akut och cancerrelaterad smärta. Smärtmedicin vol. 1. Stockholm: Liber AB; 2019.

  5. Glare PA, Davies PS, Finlay E, Gulati A, Lemanne D, Moryl N, et al. Pain in cancer survivors. J Clin Oncol. 2014;32(16):1739-47.

  6. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333.

  7. Gerdle B BE, Roeck-Hansen E, Rothman M, Stålnacke B-M, Westergren H, Rivano Fischer M. Smärtanalys – Diagnos, smärtmekanismer, psykologisk och socialbedömning. Lund: Studentlitteratur AB; 2020.

  8. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-82.

  9. Society SP. Omarbetad definition av smärta (översättning av IASP definition 2020) 2021 [Available from: https://www.swedishpainsociety.com/smartdefinition

  10. Bäckryd E WMU, (red). Långvarig smärta smärta. Smärtmedicin vol. 2. Stockholm: Liber AB; 2021.

  11. Bradley LA, McKendree-Smith NL. Central nervous system mechanisms of pain in fibromyalgia and other musculoskeletal disorders: behavioral and psychologic treatment approaches. Current Opinion in Rheumatology. 2002;14(1):45-51.

  12. Melzack R. Phantom limbs and the concept of a neuromatrix. Trends in neurosciences. 1990;13(3):88-92.

  13. Melzack R. From the gate to the neuromatrix. Pain. 1999; Suppl 6:S121-6.

  14. (SKR) SKoR. Nationellt Kliniskt Kunskapsstöd 2024 [Available from: https://www.nationelltklinisktkunskapsstod.se/

  15. Linton SJ, Shaw WS. Impact of Psychological Factors in the Experience of Pain. Physical therapy. 2011;91(5):700-11.

  16. Bäckryd E. Pain assessment 3 × 3: a clinical reasoning framework for healthcare professionals. Scand J Pain. 2023;23(2):268-72.

  17. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-36.

  18. Hadjistavropoulos T, Craig KD, Duck S, Cano A, Goubert L, Jackson PL, et al. A biopsychosocial formulation of pain communication. Psychological bulletin. 2011;137(6):910-39.

  19. Turk DC, Fillingim RB, Ohrbach R, Patel KV. Assessment of Psychosocial and Functional Impact of Chronic Pain. J Pain. 2016;17(9 Suppl):T21-49.

  20. Hruschak V, Cochran G. Psychosocial predictors in the transition from acute to chronic pain: a systematic review. Psychol Health Med. 2018;23(10):1151-67.

  21. Linton SJ, Boersma K, Vangronsveld K, Fruzzetti A. Painfully reassuring? The effects of validation on emotions and adherence in a pain test. Eur J Pain. 2012;16(4):592-9.

  22. Linton SJ. Intricacies of good communication in the context of pain: does validation reinforce disclosure? Pain. 2015;156(2):199-200.

  23. Greville-Harris M, Hempel R, Karl A, Dieppe P, Lynch TR. The Power of Invalidating Communication: Receiving Invalidating Feedback Predicts Threat-Related Emotional, Physiological, and Social Responses. Journal of Social and Clinical Psychology. 2016;35(6):471-93.

  24. Battison EAJ, Brown PCM, Holley AL, Wilson AC. Associations between Chronic Pain and Attention-Deficit Hyperactivity Disorder (ADHD) in Youth: A Scoping Review. Children. 2023;10(1):142.

  25. Akerblom S, Perrin S, Rivano Fischer M, McCracken LM. The Impact of PTSD on Functioning in Patients Seeking Treatment for Chronic Pain and Validation of the Posttraumatic Diagnostic Scale. International journal of behavioral medicine. 2017;24(2):249-59.

  26. Currie SR, Wang J. More data on major depression as an antecedent risk factor for first onset of chronic back pain. Psychol Med. 2005;35(9):1275-82.

  27. Rabe-Jablonska J, Miller A. [Links between pain and depression]. Psychiatr Pol. 2005;39(1):7-20.

  28. Racine M. Chronic pain and suicide risk: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):269-80.

  29. Linton SJ, Nicholas M, MacDonald S. Development of a short form of the Orebro Musculoskeletal Pain Screening Questionnaire. Spine. 2011;36(22):1891-5.

  30. Kum E, Buckley N, de Leon-Casasola O, Lema M, Busse JW. Attitudes Towards and Management of Opioid-induced Hyperalgesia: A Survey of Chronic Pain Practitioners. Clin J Pain. 2020.

  31. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain physician. 2011;14(2):145.

  32. Angst Martin S, Clark J D. Opioid-induced Hyperalgesia: A Qualitative Systematic Review. Anesthesiology. 2006;104(3):570-87.

  33. Nationella registret över smärtrehabilitering, NRS 2024-04-02 [Available from: https://www.ucr.uu.se/nrs/

  34. Läkemedelsbehandling av långvarig smärta hos barn och vuxna – behandlingsrekommendation. Information från Läkemedelsverket 2017;28(3):23-53.

  35. Feliu-Soler A, Montesinos F, Gutiérrez-Martínez O, Scott W, McCracken LM, Luciano JV. Current status of acceptance and commitment therapy for chronic pain: a narrative review. Journal of Pain Research. 2018;11(null):2145-59.

  36. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. The Lancet. 2014;384(9954):1586-96.

  37. Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110(4):1170-9.

  38. MacIntyre IM, Turtle EJ, Farrah TE, Graham C, Dear JW, Webb DJ. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial. Circulation. 2022;145(6):416-23.

  39. Ennis ZN, Dideriksen D, Vægter HB, Handberg G, Pottegård A. Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. Basic & Clinical Pharmacology & Toxicology. 2016;118(3):184-9.

  40. Concomitant use of ibuprofen and aspirin. J Pain Palliat Care Pharmacother. 2007;21(2):73-4.

  41. Solomon DH, Husni ME, Libby PA, Yeomans ND, Lincoff AM, Lϋscher TF, et al. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial. Am J Med. 2017;130(12):1415-22.e4.

  42. Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;292(4):557-74.

  43. Ballantyne JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg. 2017;125(5):1769-78.

  44. Ballantyne JC. The brain on opioids. PAIN. 2018;159:S24-S30.

  45. Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19-34.

  46. Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. 2018;2(2):Cd010585.

  47. Scully RE, Schoenfeld AJ, Jiang W, Lipsitz S, Chaudhary MA, Learn PA, et al. Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures. JAMA Surg. 2018;153(1):37-43.

  48. Deborah Dowell MKRR, MSPH; Christopher M. Jones, PharmD, DrPH; Grant T. Baldwin, PhD; Roger Chou, MD. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 20222022.

  49. Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;2015(9):Cd008659.

  50. Murphy PB, Kasotakis G, Haut ER, Miller A, Harvey E, Hasenboehler E, et al. Efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of acute pain after orthopedic trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma and the Orthopedic Trauma Association. Trauma Surg Acute Care Open. 2023;8(1):e001056.

  51. Riggin L, Ramakrishna J, Sommer DD, Koren G. A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy. Clin Otolaryngol. 2013;38(2):115-29.

  52. Gobble RM, Hoang HLT, Kachniarz B, Orgill DP. Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2014;133(3):741-55.

  53. Kelley BP, Bennett KG, Chung KC, Kozlow JH. Ibuprofen May Not Increase Bleeding Risk in Plastic Surgery: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2016;137(4):1309-16.

  54. Bongiovanni T, Marie Lancaster E, Ledesma Y, Whitaker E, Allen E, Auerbach A, et al. NSAIDs and Surgical Bleeding: What's the Bottom Line? Journal of the American College of Surgeons. 2020;231(4).

  55. Derry S, Wiffen PJ, Kalso EA, Bell RF, Aldington D, Phillips T, et al. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;5(5):Cd008609.

  56. Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, et al. Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial. Lancet (London, England). 2023;402(10398):304-12.

  57. Rehabilitering vid långvarig smärta. En systematisk litteraturöversikt. Partiell uppdatering och fördjupning av SBU-rapport nr 177/1+2. In: (SBU) Sbfmu, editor. Stockholm: 2010.

  58. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72(2):220-33.

  59. Machado GC, Maher CG, Ferreira PH, Day RO, Pinheiro MB, Ferreira ML. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis. 2017;76(7):1269-78.

  60. Socialstyrelsen. Nationella riktlinjer för rörelseorganens sjukdomar – Reumatoid artrit, axial spondylartrit, psoriasisartrit, artros och osteoporos – Stöd för styrning och ledning 2021 In: Socialstyrelsen, editor. 2021.

  61. Ackermann PW, Alim MA, Pejler G, Peterson M. Tendon pain - what are the mechanisms behind it? Scand J Pain. 2023;23(1):14-24.

  62. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24(6):469-78.

  63. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-30.

  64. Manhapra A, Sullivan MD, Ballantyne JC, MacLean RR, Becker WC. Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and Policy Changes. J Gen Intern Med. 2020;35(Suppl 3):964-71.

  65. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. JAMA. 2016;315(15):1624-45.

  66. Balanaser M, Carley M, Baron R, Finnerup NB, Moore RA, Rowbotham MC, et al. Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis. PAIN. 2023;164(2):230-51.

  67. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology. 2015;14(2):162-73.

  68. Läkemedelskommitte KLRS. Neuropatisk smärta 2024 [Available from: https://klokalistan.se/terapiomrade/smarta-och-inflammation/neuropatisk-smarta.html

  69. Toth C. Substitution of Gabapentin Therapy with Pregabalin Therapy in Neuropathic Pain due to Peripheral Neuropathy. Pain Medicine. 2010;11(3):456-65.

  70. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;2014(1):Cd007115.

  71. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2015(7).

  72. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(3):191-204.

  73. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700.

  74. Sandlund C. Insomnia: treatment needs, effectiveness, and experiences. Stockholm: Stockholm Karolinska Institutet; 2018.

  75. Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018;70(2):197-245.

  76. Läkemedelskommitteerna i regionerna Dalarna G, Jämtland Härjedalen, Jönköpings län, Kalmar län, Kronoberg, Sörmland, Uppsala, Värmland, Västernorrland, Västmanland och Örebro. Läkemedelsbehandlingav de mest sjuka och sköra äldre, behandlingsrekommendationer 2024.

  77. Läkemedelskommitté RS. Janusinfo 19240604 [Available from: https://janusinfo.se/behandling/expertgruppsutlatanden/aldreshalsa/aldreshalsa/kloklakemedelsbehandlingfordemestsjukaaldre/bakgrundsmaterial/smartlindring.5.3da1c377162bd90d9ee92bf.html

  78. Janusinfo - kloka listan. Smärta hos äldre. Available from: https://klokalistan.se/4.6807c775188bdd453dc9ca22.html#%C3%84ldre_och_l%C3%A4kemedel

  79. Socialstyrelsen. Indikatorer för god läkemedelsterapi hos äldre. In: Socialstyrelsen, editor. 2017.

  80. Guidelines NifhaceN. Osteoarthritis in over 16s: diagnosis and management2022. Available from: https://www.nice.org.uk/guidance/ng226

  81. Claes L. FAS UT 2024 Att utvärdera, ifrågasätta och skonsamt avsluta läkemedelsbehandling. Lund: Studentlitteratur AB; 2023.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida